Chronic inflammation in the etiology of disease across the life span.
Furman D, Campisi J, Verdin E, Carrera-Bastos P, Targ S, Franceschi C, Ferrucci L, Gilroy DW, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM.
Nat Med. 2019 Dec;25(12):1822-1832. doi: 10.1038/s41591-019-0675-0. Epub 2019 Dec 5.
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review.
Mahapatra MK, Karuppasamy M, Sahoo BM.
Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.
SGLT inhibitors for improving Healthspan and lifespan.
O'Keefe JH, Weidling R, O'Keefe EL, Franco WG.
Prog Cardiovasc Dis. 2023 Nov-Dec;81:2-9. doi: 10.1016/j.pcad.2023.10.003. Epub 2023 Oct 17.
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology.
Shimano H, Sato R.
Nat Rev Endocrinol. 2017 Dec;13(12):710-730. doi: 10.1038/nrendo.2017.91. Epub 2017 Aug 29.
GLP-1a: Going beyond Traditional Use.
Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, Araújo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Oliveira Silva Ullmann T, Sloan KP, Sloan LA.
Int J Mol Sci. 2022 Jan 10;23(2):739. doi: 10.3390/ijms23020739.
Consequences of Disturbing Manganese Homeostasis.
Baj J, Flieger W, Barbachowska A, Kowalska B, Flieger M, Forma A, Teresiński G, Portincasa P, Buszewicz G, Radzikowska-Büchner E, Flieger J.
Int J Mol Sci. 2023 Oct 6;24(19):14959. doi: 10.3390/ijms241914959.
Nutritional Risk Factors, Microbiota and Parkinson's Disease: What Is the Current Evidence?
Boulos C, Yaghi N, El Hayeck R, Heraoui GN, Fakhoury-Sayegh N.
Nutrients. 2019 Aug 14;11(8):1896. doi: 10.3390/nu11081896.
Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.
Peng B, Yang Q, B Joshi R, Liu Y, Akbar M, Song BJ, Zhou S, Wang X.
Int J Mol Sci. 2020 Mar 27;21(7):2316. doi: 10.3390/ijms21072316.
Therapeutic application of natural products: NAD+ metabolism as potential target.
Guo C, Huang Q, Wang Y, Yao Y, Li J, Chen J, Wu M, Zhang Z, E M, Qi H, Ji P, Liu Q, Zhao D, Su H, Qi W, Li X.
Phytomedicine. 2023 Jun;114:154768. doi: 10.1016/j.phymed.2023.154768. Epub 2023 Mar 13.
Young-onset dementia diagnosis, management and care: a narrative review.
Loi SM, Cations M, Velakoulis D.
Med J Aust. 2023 Mar 6;218(4):182-189. doi: 10.5694/mja2.51849. Epub 2023 Feb 19.
